| Date Filed | Type | Description |
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 18,500 options to buy
@ $21.37, valued at
$395.3k
|
|
| 06/11/2020 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 3,427 options to buy
@ $8.69, valued at
$29.8k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/08/2019 |
4/A
| MCGIRR DAVID W J (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 22,500 options
@ $6.02, valued at
$135.5k
|
|
| 06/27/2019 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 22,500 options
@ $6.02, valued at
$135.5k
|
|
| 06/21/2019 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 15,000 options to buy
@ $22.93, valued at
$344k
|
|
| 06/19/2019 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on X4 Pharmaceuticals, Inc|
Txns:
| Granted 3,427 options to buy
@ $14.75, valued at
$50.5k
|
|
| 05/16/2019 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 6,899 shares
@ $0 |
|
| 06/08/2018 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.|
Txns:
| Granted 10,000 options to buy
@ $34.89, valued at
$348.9k
|
|
| 06/07/2018 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 10,000 options to buy
@ $16.99, valued at
$169.9k
|
|
| 05/17/2018 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on INSMED Inc|
Txns:
| Granted 6,066 shares
@ $0 |
|
| 03/05/2018 |
4/A
| MCGIRR DAVID W J (Director) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 25,000 options to buy
@ $10, valued at
$250k
|
|
| 01/24/2018 |
3
| MCGIRR DAVID W J (Director) has filed a Form 3 on Menlo Therapeutics, Inc. |
| 12/01/2017 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on Arsanis, Inc.|
Txns:
| Granted 7,324 options to buy
@ $10, valued at
$73.2k
|
|
| 11/15/2017 |
3
| MCGIRR DAVID W J (Director) has filed a Form 3 on Arsanis, Inc. |
| 10/04/2017 |
3
| MCGIRR DAVID W J (Director) has filed a Form 3 on RHYTHM PHARMACEUTICALS, INC. |
| 06/30/2017 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on Roka BioScience, Inc.|
Txns:
| Granted 3,000 options to buy
@ $2.55, valued at
$7.7k
|
|
| 05/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/02/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/24/2016 |
4
| MCGIRR DAVID W J (Director) has filed a Form 4 on Roka BioScience, Inc. |
| 06/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/01/2013 |
3
| MCGIRR DAVID W J (Director) has filed a Form 3 on INSMED INC |
| 02/20/2013 |
4
| MCGIRR DAVID W J (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Granted 4,807 restricted stock units
@ $0
Exercised 1,500 restricted stock units
@ $0 |
|
| 09/24/2012 |
4
| MCGIRR DAVID W J (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Sold 15,000 shares
@ $49.79, valued at
$746.9k
Exercised 15,000 options to buy
@ $10.35, valued at
$155.3k
|
|
| 08/27/2012 |
4
| MCGIRR DAVID W J (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Sold 20,000 shares
@ $45.6935, valued at
$913.9k
Exercised 20,000 options to buy
@ $10.35, valued at
$207k
|
|
| 05/16/2012 |
4
| MCGIRR DAVID W J (SVP & CFO) has filed a Form 4 on CUBIST PHARMACEUTICALS INC|
Txns:
| Exercised 1,875 restricted stock units
@ $0
Exercised 1,600 restricted stock units
@ $0 |
|
|